Oncimmune Plc (LSE: ONC)
Some price data may be temporarily unavailable.
Oncimmune Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Oncimmune Plc Company Info
Oncimmune Holdings Plc engages in diagnosing cancer. It is involved in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes Early CDT Lung and ImmunoINSIGHTS. The company was founded in 2002 and is headquartered in Nottinghamshire, the United Kingdom.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.